α-methyltryptophan-mediated protection against diabetic nephropathy in db/db mice as studied with a metabolomics approach
Aimin Cai, Dingchao Shen, Qiushuang Xiong, Jie Ding, Yang Ding, Xinlu Lin, Lijia Chen, Qing Yao, Guangyong Lin, Ruijie Chen, Vadivel Ganapathy, Longfa Kou · 2025
Read α-methyltryptophan-mediated protection against diabetic nephropathy in db/db mice as studied with a metabolomics approach by Aimin Cai, Dingchao Shen, Qiushuang Xiong, Jie Ding, Yang Ding, Xinlu Lin, Lijia Chen, Qing Yao, Guangyong Lin, Ruijie Chen, Vadivel Ganapathy, Longfa Kou (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11788373.txt.
Description
Aimin Cai and co-authors test a compound against diabetic kidney harm in mice, in a paper whose head is dated 2024. The compound blocks a transport protein and an enzyme called IDO1. Diabetic kidney disease harms patients for life and still lacks strong cures.
In a mouse strain prone to diabetes, the compound cut protein loss in urine and eased kidney scarring. Chemical maps of kidney and urine showed high IDO1 activity and broad metabolic upset in sick mice. The upset touched amino acids, energy paths, and cell signals tied to growth and cell death. Treatment curbed IDO1 and steadied much of the upset, the team report.
Catalog record
| CREATOR | Aimin Cai, Dingchao Shen, Qiushuang Xiong, Jie Ding, Yang Ding, Xinlu Lin, Lijia Chen, Qing Yao, Guangyong Lin, Ruijie Chen, Vadivel Ganapathy, Longfa Kou |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |